Grant Verstandig is a Co-Founder at Red Cell Partners and the Chairman and Chief Executive Officer. He is also the Co-Founder and Executive Chairman at Zephyr AI, DEFCON AI, and TARA Mind, all Red Cell incubations. Mr. Verstandig is an accomplished entrepreneur, venture capital investor, and seasoned executive who has founded and scaled numerous businesses including Rally Health, a consumer centric digital health company acquired by UnitedHealth Group; Epirus, an AI-enabled power management company focused on directed energy defense applications, and Spycraft Entertainment, a production company focused on intelligence and military operations. From 2017 to 2021, Mr. Verstandig served as Chief Digital Officer of UnitedHealth Group where he was responsible for the strategic direction, governance, and performance expectations of digital platforms and capabilities; he now serves as Senior Advisor to the CEO. Mr. Verstandig is a civic leader, philanthropist, and advisor to many public, nonprofit, and government organizations. He serves as a senior advisor to the National Security Agency on advanced analytics, technology, and artificial intelligence and holds several patents in these fields. Mr. Verstandig is a member of the Aspen Institute's Cybersecurity Group, the nation's leading cross-sector public-private cybersecurity forum that aims to translate pressing cybersecurity topics into action. He is a member of the National Council for American Enterprise and serves on the boards of Third Option Foundation, the International Spy Museum, and the Greater Washington Partnership, where he is a founding member. Mr. Verstandig is an active supporter of the Greater Washington area hospitals: Children’s Hospital, Inova, and MedStar-Georgetown. He is the Founder and Chairman of Verstandig Family Foundation (VFF) which has been a longtime supporter of VETS®, Veterans Exploring Treatment Solutions, Seton Hill University and the Grant Scholars Program, The Aspen Institute’s Foreign Ministers Program, and the new Aspen Global Digital Program.